OMNICELL INC (OMCL) Stock Fundamental Analysis
NASDAQ:OMCL - Nasdaq - US68213N1090 - Common Stock - Currency: USD
OMCL gets a fundamental rating of 4 out of 10. The analysis compared the fundamentals against 189 industry peers in the Health Care Equipment & Supplies industry. OMCL has an average financial health and profitability rating. OMCL has a decent growth rate and is not valued too expensively.
1. Profitability
1.1 Basic Checks
In the past year OMCL was profitable.
OMCL had a positive operating cash flow in the past year.
OMCL had positive earnings in 4 of the past 5 years.
Each year in the past 5 years OMCL had a positive operating cash flow.
1.2 Ratios
The Return On Assets of OMCL (0.59%) is better than 73.02% of its industry peers.
Looking at the Return On Equity, with a value of 1.01%, OMCL is in the better half of the industry, outperforming 74.07% of the companies in the same industry.
With a decent Return On Invested Capital value of 0.28%, OMCL is doing good in the industry, outperforming 66.14% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 0.59% | ||
| ROE | 1.01% | ||
| ROIC | 0.28% |
ROA(3y)-0.02%
ROA(5y)1.07%
ROE(3y)-0.07%
ROE(5y)1.98%
ROIC(3y)N/A
ROIC(5y)N/A
1.3 Margins
With a decent Profit Margin value of 1.13%, OMCL is doing good in the industry, outperforming 73.55% of the companies in the same industry.
In the last couple of years the Profit Margin of OMCL has declined.
Looking at the Operating Margin, with a value of 0.49%, OMCL is in the better half of the industry, outperforming 65.08% of the companies in the same industry.
OMCL's Operating Margin has declined in the last couple of years.
With a Gross Margin value of 42.75%, OMCL is not doing good in the industry: 66.14% of the companies in the same industry are doing better.
OMCL's Gross Margin has declined in the last couple of years.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 0.49% | ||
| PM (TTM) | 1.13% | ||
| GM | 42.75% |
OM growth 3Y-60.62%
OM growth 5Y-43.72%
PM growth 3Y-45.27%
PM growth 5Y-30.27%
GM growth 3Y-4.46%
GM growth 5Y-2.57%
2. Health
2.1 Basic Checks
The Return on Invested Capital (ROIC) is below the Cost of Capital (WACC), so OMCL is destroying value.
OMCL has more shares outstanding than it did 1 year ago.
The number of shares outstanding for OMCL has been increased compared to 5 years ago.
Compared to 1 year ago, OMCL has an improved debt to assets ratio.
2.2 Solvency
An Altman-Z score of 1.91 indicates that OMCL is not a great score, but indicates only limited risk for bankruptcy at the moment.
Looking at the Altman-Z score, with a value of 1.91, OMCL is in the better half of the industry, outperforming 61.90% of the companies in the same industry.
The Debt to FCF ratio of OMCL is 2.53, which is a good value as it means it would take OMCL, 2.53 years of fcf income to pay off all of its debts.
Looking at the Debt to FCF ratio, with a value of 2.53, OMCL belongs to the top of the industry, outperforming 88.36% of the companies in the same industry.
OMCL has a Debt/Equity ratio of 0.13. This is a healthy value indicating a solid balance between debt and equity.
Looking at the Debt to Equity ratio, with a value of 0.13, OMCL is in line with its industry, outperforming 57.14% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.13 | ||
| Debt/FCF | 2.53 | ||
| Altman-Z | 1.91 |
ROIC/WACC0.04
WACC7.63%
2.3 Liquidity
OMCL has a Current Ratio of 1.37. This is a normal value and indicates that OMCL is financially healthy and should not expect problems in meeting its short term obligations.
With a Current ratio value of 1.37, OMCL is not doing good in the industry: 77.78% of the companies in the same industry are doing better.
OMCL has a Quick Ratio of 1.22. This is a normal value and indicates that OMCL is financially healthy and should not expect problems in meeting its short term obligations.
Looking at the Quick ratio, with a value of 1.22, OMCL is doing worse than 71.43% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 1.37 | ||
| Quick Ratio | 1.22 |
3. Growth
3.1 Past
The earnings per share for OMCL have decreased strongly by -10.99% in the last year.
OMCL shows a decrease in Earnings Per Share. Measured over the last years, the EPS has been decreasing by -9.56% yearly.
Looking at the last year, OMCL shows a decrease in Revenue. The Revenue has decreased by -3.04% in the last year.
OMCL shows a small growth in Revenue. Measured over the last years, the Revenue has been growing by 4.40% yearly.
EPS 1Y (TTM)-10.99%
EPS 3Y-23.52%
EPS 5Y-9.56%
EPS Q2Q%81.82%
Revenue 1Y (TTM)-3.04%
Revenue growth 3Y-0.59%
Revenue growth 5Y4.4%
Sales Q2Q%18.56%
3.2 Future
OMCL is expected to show quite a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 8.18% yearly.
OMCL is expected to show quite a strong growth in Revenue. In the coming years, the Revenue will grow by 14.90% yearly.
EPS Next Y7%
EPS Next 2Y8.65%
EPS Next 3Y8.18%
EPS Next 5YN/A
Revenue Next Year2.4%
Revenue Next 2Y3.4%
Revenue Next 3Y4.33%
Revenue Next 5Y14.9%
3.3 Evolution
The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
4. Valuation
4.1 Price/Earnings Ratio
The Price/Earnings ratio is 18.43, which indicates a rather expensive current valuation of OMCL.
83.07% of the companies in the same industry are more expensive than OMCL, based on the Price/Earnings ratio.
OMCL is valuated rather cheaply when we compare the Price/Earnings ratio to 28.88, which is the current average of the S&P500 Index.
With a Price/Forward Earnings ratio of 17.22, OMCL is valued on the expensive side.
OMCL's Price/Forward Earnings ratio is rather cheap when compared to the industry. OMCL is cheaper than 82.54% of the companies in the same industry.
The average S&P500 Price/Forward Earnings ratio is at 21.20. OMCL is around the same levels.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 18.43 | ||
| Fwd PE | 17.22 |
4.2 Price Multiples
Based on the Enterprise Value to EBITDA ratio, OMCL is valued a bit cheaper than 79.89% of the companies in the same industry.
OMCL's Price/Free Cash Flow ratio is rather cheap when compared to the industry. OMCL is cheaper than 94.71% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 10.88 | ||
| EV/EBITDA | 14.42 |
4.3 Compensation for Growth
The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates an expensive valuation of the company.
PEG (NY)2.63
PEG (5Y)N/A
EPS Next 2Y8.65%
EPS Next 3Y8.18%
5. Dividend
5.1 Amount
No dividends for OMCL!.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
NASDAQ:OMCL (5/1/2025, 1:45:37 PM)
31.33
+0.07 (+0.22%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)
Earnings (Next)
Inst Owners103.01%
Inst Owner Change-0.8%
Ins Owners1.34%
Ins Owner Change28.99%
Market Cap1.47B
Analysts74.67
Price Target54.06 (72.55%)
Short Float %5.22%
Short Ratio4.04
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)18.51%
Min EPS beat(2)1.42%
Max EPS beat(2)35.6%
EPS beat(4)4
Avg EPS beat(4)103.5%
Min EPS beat(4)1.42%
Max EPS beat(4)245.61%
EPS beat(8)8
Avg EPS beat(8)139.71%
EPS beat(12)11
Avg EPS beat(12)115.48%
EPS beat(16)14
Avg EPS beat(16)89.87%
Revenue beat(2)1
Avg Revenue beat(2)-0.43%
Min Revenue beat(2)-1.27%
Max Revenue beat(2)0.42%
Revenue beat(4)3
Avg Revenue beat(4)1.85%
Min Revenue beat(4)-1.27%
Max Revenue beat(4)6.33%
Revenue beat(8)5
Avg Revenue beat(8)1.43%
Revenue beat(12)6
Avg Revenue beat(12)0.18%
Revenue beat(16)8
Avg Revenue beat(16)0.12%
PT rev (1m)-1.59%
PT rev (3m)-6.31%
EPS NQ rev (1m)0%
EPS NQ rev (3m)-35.79%
EPS NY rev (1m)0%
EPS NY rev (3m)-1.65%
Revenue NQ rev (1m)-0.07%
Revenue NQ rev (3m)-3.83%
Revenue NY rev (1m)-0.26%
Revenue NY rev (3m)-2.7%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 18.43 | ||
| Fwd PE | 17.22 | ||
| P/S | 1.32 | ||
| P/FCF | 10.88 | ||
| P/OCF | 7.82 | ||
| P/B | 1.18 | ||
| P/tB | 5.6 | ||
| EV/EBITDA | 14.42 |
EPS(TTM)1.7
EY5.43%
EPS(NY)1.82
Fwd EY5.81%
FCF(TTM)2.88
FCFY9.19%
OCF(TTM)4.01
OCFY12.79%
SpS23.75
BVpS26.54
TBVpS5.59
PEG (NY)2.63
PEG (5Y)N/A
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 0.59% | ||
| ROE | 1.01% | ||
| ROCE | 0.36% | ||
| ROIC | 0.28% | ||
| ROICexc | 0.39% | ||
| ROICexgc | 3.02% | ||
| OM | 0.49% | ||
| PM (TTM) | 1.13% | ||
| GM | 42.75% | ||
| FCFM | 12.13% |
ROA(3y)-0.02%
ROA(5y)1.07%
ROE(3y)-0.07%
ROE(5y)1.98%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5Y-30.61%
ROICexc growth 3Y-63.57%
ROICexc growth 5Y-44.11%
OM growth 3Y-60.62%
OM growth 5Y-43.72%
PM growth 3Y-45.27%
PM growth 5Y-30.27%
GM growth 3Y-4.46%
GM growth 5Y-2.57%
F-Score6
Asset Turnover0.52
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.13 | ||
| Debt/FCF | 2.53 | ||
| Debt/EBITDA | 1.75 | ||
| Cap/Depr | 58.82% | ||
| Cap/Sales | 4.75% | ||
| Interest Coverage | 3.38 | ||
| Cash Conversion | 197.09% | ||
| Profit Quality | 1076.76% | ||
| Current Ratio | 1.37 | ||
| Quick Ratio | 1.22 | ||
| Altman-Z | 1.91 |
F-Score6
WACC7.63%
ROIC/WACC0.04
Cap/Depr(3y)62.08%
Cap/Depr(5y)71.19%
Cap/Sales(3y)4.74%
Cap/Sales(5y)5.11%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-10.99%
EPS 3Y-23.52%
EPS 5Y-9.56%
EPS Q2Q%81.82%
EPS Next Y7%
EPS Next 2Y8.65%
EPS Next 3Y8.18%
EPS Next 5YN/A
Revenue 1Y (TTM)-3.04%
Revenue growth 3Y-0.59%
Revenue growth 5Y4.4%
Sales Q2Q%18.56%
Revenue Next Year2.4%
Revenue Next 2Y3.4%
Revenue Next 3Y4.33%
Revenue Next 5Y14.9%
EBIT growth 1Y128.18%
EBIT growth 3Y-60.85%
EBIT growth 5Y-41.24%
EBIT Next Year104.58%
EBIT Next 3Y35.71%
EBIT Next 5YN/A
FCF growth 1Y7.02%
FCF growth 3Y-8.04%
FCF growth 5Y10.13%
OCF growth 1Y3.66%
OCF growth 3Y-6.79%
OCF growth 5Y5.3%